Recalls / Class II
Class IID-0764-2020
Product
QUADMIX 30MG/2MG/20MCG/100MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800
- Affected lot / code info
- Lots: 07012019@30 Exp. 12/28/2019; 08052019@13 Exp. 02/01/2020; 09252019@15 Exp. 03/23/2020; 10292019@12 Exp. 04/26/2020; 10092019@6 Exp. 03/04/2020; 10162019@12 Exp. 04/13/2020; 12042019@31 Exp. 01/18/2020; 12162019@35 Exp. 01/30/2020; 11262019@37 Exp. 05/24/2020
Why it was recalled
Lack of sterility assurance.
Recalling firm
- Firm
- Assurance Infusion
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 2626 S Loop W Ste 555, Houston, Texas 77054-2652
Distribution
- Quantity
- 190 vials
- Distribution pattern
- Nationwide within the United States
Timeline
- Recall initiated
- 2019-12-20
- FDA classified
- 2020-01-13
- Posted by FDA
- 2020-01-22
- Terminated
- 2021-10-27
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0764-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.